Teva And Kowa Partner For 50-50 Stake In Japanese Generic Firm

TOKYO - Japanese drug maker Kowa said Sept. 24 that it had signed a definitive agreement with Israel generic manufacturer Teva Pharmaceutical to share a 50-50 stake in a generic manufacturer in Japan to take advantage of a growing Japanese generics market

More from Archive

More from Scrip